SNNSF yields 6680.03% · PFE yields 6.13%● Live data
📍 SNNSF pulled ahead of the other in Year 1
Combined, SNNSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNNSF + PFE for your $10,000?
SenSen Networks Limited develop and sell SenDISA platform-based products and services in Australia. It operates through Smart Cities, Gaming, and Retail segments. The company offers SenDISA software platform-based products and solutions for multiple applications comprising law enforcement, transport, gaming, retail, logistics, manufacturing, defence and security, autonomous vehicles, and transportation. Its software combines enterprise video, sensor data analytics, and edge-to-cloud servers that allows customers to make fast and accurate decisions and to automate business processes. The company also provides cities solutions like smart curb management, including fixed and mobile cameras and sensors; smart parking, such as parking guidance, payment and permit compliance, and automated access control, as well as occupancy, parking duration studies, and emerging data application solutions; infrastructure audits, including sign digitisation and audit and digitisation of city assets and audits, as well as road works signage and road infrastructure audits; road safety solutions, such as spot and average speed, distracted driver detection, u-turn enforcement, and bus lane enforcement solutions; and traffic and tolling solutions. In addition, it offers casino solutions, such as live table game data, real time intelligence, and side bet utilization solutions, as well as SenEYE-D to recognize who is playing and matching your database/system; and retail solutions. Further, the company provides smart surveillance solutions, such as multi-camera tracking, surveillance camera and network audit, accurate live occupancy, and fast and simple video export, as well as work, health, and safety solutions; and emerging solutions, including blind bots, games AI, tag and trace, and smart cub sensor. SenSen Networks Limited was incorporated in 2006 and is headquartered in Melbourne, Australia.
Full SNNSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.